Diseases
Atherosclerosis I
Co-sponsored by the Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology
Chairs: Katey Rayner, University of Ottawa Heart Institute and
Francis W. Luscinskas, Brigham and Women's Hospital/Harvard Medical School
Matthias Nahrendorf, Harvard Medical School
Inflammatory networks in cardiovascular disease
Ziad Mallat, University of Cambridge
Targeting the immune response in ischemic cardiovascular disease
Atherosclerosis II
Co-sponsored by the Korean Vascular Science and Medicine Organization
Chairs: Michael Gimbrone, Brigham and Women's Hospital/Harvard Medical School and
Jun-ichi Abe, University of Texas MD Anderson
Hyo-Soo Kim, Seoul National University Hospital
Mechanism of calcification in atherosclerosis:
Role of bone-marrow-derived calcifying progenitors
Ira Tabas, Columbia University
Defective inflammation resolution in atherosclerosis: Mechanisms and therapeutic implications
Atherosclerosis III
Co-sponsored by the Japanese Vascular Biology and Medicine Organization
Chairs: Myron Cybulsky, Univeristy of Toronto and Yasufumi Sato, Tohoku University
Eicke Latz, University Hospital, University of Bonn
Innate immune memory in atherosclerosis
Masataka Sata, Tokushima University Graduate School
Role of innate immunity in chronic inflammation in arterial wall and adipose tissue
Large Vessel Disease Outside the Heart
Co-sponsored by the Japanese Vascular Biology and Medicine Organization
Chairs: Phillip Tsao, Stanford University and Hironori Nakagami, Osaka University
Brian Annex, University of Virginia
Micro-RNA’s in Peripheral Arterial Disease
Ryuichi Morishita, Osaka University
Recent progress in molecular medicine on critical limb ischemia:
From regenerative medicine to vaccine
Neurovascular Disease
Chairs: Elisabetta Dejana, University of Uppsala and Chenghua Gu, Harvard Medical School
Anne Joutel, INSERM - University of Paris
Novel insight into the pathogenesis of CADASIL
Costantino Iadecola, Weill Cornell Medical College
Neurovascular dysfunction and cognitive impairment
Pulmonary Hypertension
Chairs: Paul Yu, Brigham and Women's Hospital/Harvard Medical School and
Troy Stevens, University of Alabama
Kurt Stenmark, University of Colorado Denver
Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension
Evangelos Michelakis, University of Alberta
The metabolic basic of vascular disease and pulmonary arterial hypertension
Vascular Malformations
Co-sponsored by Cure HHT
Chairs: Ondine Cleaver, University of Texas Southwestern Medical Center and
Joyce Bischoff, Boston Children's Hospita/Harvard Medical School
Miikka Vikkula, de Duve Institute, Université catholique de Louvain
Deciphering the heterogeneity of vascular malformations by next generation sequencing
Douglas Marchuk, Duke University
Cerebral cavernous malformations: From gene discovery to potential therapy
Cancer
Co-sponsored by the Korean Vascular Science and Medicine Organization
Chairs: Gabriele Bergers, University of Leuven and
Diane Bielenberg, Boston Children's Hospita/Harvard Medical School
Anna Dimberg, Uppsala University
Vascular abnormalization in glioblastoma
Gou Young Koh, KAIST
Molecular targeting of tumor vasculatures
Obesity/Diabetes
Chair: Zoltan Arany, University of Pennsylvania
Kenneth Walsh, Boston University School of Medicine
Role of adipokines in obesity-linked vascular disease
Ann Marie Schmidt, NYU School of Medicine
RAGE & the Formin DIAPH1 & mechanisms of diabetic complications
Thrombosis
Chairs: Nigel Mackman, Univeristy of North Carolina and Xiaoping Du, University of Illinois Chicago
Denisa Wagner, Harvard Medical School
Pathological impact of Neutrophil Extracellular Traps (NETs)
Jose Lopez, Puget Sound Blood Center
Regulation of von Willebrand factor adhesive function